<?xml version="1.0" encoding="UTF-8"?>
<p>Interestingly, it appears that effects of sex hormones on the neuroimmune system may also account for the well‚Äêknown higher incidence of chronic pain and increased sensitivity to pain in women.
 <xref rid="prp2532-bib-0113" ref-type="ref">113</xref> Schizophrenia, though, is more frequent in young males (2:1) than in females, whereas this ratio is reversed in adulthood, probably because of protective effects of estradiol.
 <xref rid="prp2532-bib-0114" ref-type="ref">114</xref> A sex difference has also been repeatedly reported in the incidence of and drug efficacy in depression in men and women, whereas sex differences have also been found in animal models of depression. Consequently, it is more relevant for subsequent clinical development, especially in terms of autoimmune and neurological diseases, to use female animals or at least animals of both sexes, in early compound testing.
 <xref rid="prp2532-bib-0115" ref-type="ref">115</xref> In fact, the US National Institutes of Health have recommended that the sex of animals and of cells be balanced for preclinical research studies.
 <xref rid="prp2532-bib-0116" ref-type="ref">116</xref> The US Federal Drug Administration encourages pharmaceutical and medical device companies to provide data from clinical trials derived from both men and women.
 <xref rid="prp2532-bib-0117" ref-type="ref">117</xref> This, however, means that the number of animals or human subjects to be included in trials is increased for statistical reasons, a fact that needs to be taken into account by local regulatory authorities.
</p>
